These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6315736)

  • 1. Innocuity testing of foot-and-mouth disease vaccines. I. Formaldehyde-inactivated alhydrogel vaccines.
    Barteling SJ; Woortmeyer R; Visser N
    J Biol Stand; 1983 Oct; 11(4):297-304. PubMed ID: 6315736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification, characterisation and safety testing of foot-and-mouth disease virus antigens eluted from alhydrogel vaccines.
    Visser N; Woortmeyer R
    Dev Biol Stand; 1981; 50():277-83. PubMed ID: 6176487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innocuity testing of foot-and-mouth disease vaccines. II. Aziridine-inactivated antigen produced in baby hamster kidney cells.
    Barteling SJ
    J Biol Stand; 1983 Oct; 11(4):305-12. PubMed ID: 6315737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conditions for proper formaldehyde inactivation of foot and mouse disease alhydrogel vaccines.
    Barteling SJ
    Dev Biol Stand; 1985; 60():323-9. PubMed ID: 2995172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formaldehyde inactivation of foot-and-mouth disease virus. Conditions for the preparation of safe vaccine.
    Barteling SJ; Woortmeyer R
    Arch Virol; 1984; 80(2-3):103-17. PubMed ID: 6326708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Methods of testing of safety of the anti-foot-and-mouth disease vaccine].
    Dannacher G; Fédida M; Coudert M; Perrin M
    Dev Biol Stand; 1976; 35():271-8. PubMed ID: 198294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenging settled opinions in classic foot-and-mouth disease vaccine preparation.
    Barteling SJ; Anemaet DA
    Dev Biol Stand; 1987; 66():531-8. PubMed ID: 3034709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Safety of foot-and-mouth disease vaccines in cell cultures].
    Tekerlekov P; Dilovski M; Gergov P; Nikolova E
    Vet Med Nauki; 1982; 19(1):21-5. PubMed ID: 6287707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of virus-infection-associated (VIA) antigen of foot-and-mouth disease (FMD) virus from inactivated vaccine.
    Sugimura T; Tsuda T; Suzuki T; Murakami Y
    J Vet Med Sci; 1996 Jun; 58(6):599-601. PubMed ID: 8811637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Developments in foot-and-mouth disease (FMD) vaccine production (author's transl)].
    Barteling SJ
    Tijdschr Diergeneeskd; 1980 Sep; 105(17):695-8. PubMed ID: 6252656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The suitability of a rolled BHK21 monolayer system for the production of vaccines against the SAT types of foot-and-mouth disease virus. I. Adaptation of virus isolates to the system, immunogen yields achieved and assessment of subtype cross reactivity.
    Esterhuysen JJ; Thomson GR; Ashford WA; Lentz DW; Gainaru MD; Sayer AJ; Meredith CD; Janse van Rensburg D; Pini A
    Onderstepoort J Vet Res; 1988 Jun; 55(2):77-84. PubMed ID: 2839810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study on the immune response of sheep to foot and mouth disease virus vaccine type 'O' prepared with different inactivants and adjuvants.
    Nair SP; Sen AK
    Acta Virol; 1992 Oct; 36(5):473-8. PubMed ID: 1364024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative testing of the quality of foot-and-mouth disease vaccines prepared with different virus inactivators].
    Dilovski M; Tekerlekov P
    Vet Med Nauki; 1983; 20(5-6):41-5. PubMed ID: 6318423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attempts at potency testing of foot-and-mouth disease vaccines by evaluation of the complement fixing capacity of eluates.
    Bauer K
    Dev Biol Stand; 1976; 35():297-300. PubMed ID: 198299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure and immunogenicity of experimental foot-and-mouth disease and poliomyelitis vaccines.
    Twomey T; Newman J; Burrage T; Piatti P; Lubroth J; Brown F
    Vaccine; 1995 Nov; 13(16):1603-10. PubMed ID: 8578849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of acetylethyleneimine upon a strain of inactivated foot-and-mouth disease virus stored at 4 degrees C.
    Staple RF; Morrow AW; Fletton BW
    Arch Virol; 1975; 47(4):331-5. PubMed ID: 166627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Very fast (and safe) inactivation of foot-and-mouth disease virus and enteroviruses by a combination of binary ethyleneimine and formaldehyde.
    Barteling SJ; Cassim NI
    Dev Biol (Basel); 2004; 119():449-55. PubMed ID: 15742659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Some problems of testing foot-and-mouth disease vaccines. I. Innocuity testing.
    Soós T
    Acta Vet Hung; 1987; 35(3):319-30. PubMed ID: 2829601
    [No Abstract]   [Full Text] [Related]  

  • 19. The stability and potency of vaccines prepared from inactivated foot-and-mouth disease virus concentrates.
    Doel TR; David DJ
    J Biol Stand; 1984 Jul; 12(3):247-55. PubMed ID: 6090464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune response to virus-infection-associated (VIA) antigen in cattle repeatedly vaccinated with foot-and-mouth disease virus inactivated by formalin or acetylethyleneimine.
    Pinto AA; Garland AJ
    J Hyg (Lond); 1979 Feb; 82(1):41-50. PubMed ID: 216744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.